Results 5,621-5,640 of 34,616 for speaker:Seán Fleming
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: The guaranteed maximum price was discussed extensively at the health committee. Mr. Breslin mentioned an internal report. Did the Department get external consultant assistance in that regard?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: Appendix 6 of the report I am holding up-----
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: It is the international hospital consultant benchmarking report for the national paediatric hospital dated 25 October from a company called AECOM. Are they internal or external consultants?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: It is the international benchmark.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: Am I correct that external consultants were involved in this report?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: The guaranteed maximum price.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: Appendix 6.2 is another report entitled Construction Inflation Overview from a company called Linesight.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: Perhaps Mr. Breslin will elaborate because I got the impression the report was carried out internally. It now appears it was done with the assistance of several external people.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I ask one of the witnesses to take me through what happened from Linesight to AECOM, the Department's report, the Mazars report the following week, the HSE report, incorporating PwC input, a week later and then the PwC report the following month.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I think I have the sequence right.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I ask Mr. Breslin to explain it for the benefit of the public.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: People are bamboozled by all of this.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I ask Mr. Breslin to explain to the public why there was an imperative for a timeline. Would the Department have had to pay compensation if it delayed the project?
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: In other words, the rush was related to the fact that BAM had included in its original tender that if there was any delay in reaching a decision in regard to phase 2, there would be a cost to the taxpayer for delaying BAM getting on with the job.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: The witnesses' backs were to the wall.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I am sure Mr. Barry will agree that it was a dreadful position for taxpayers to be put in on day one that if there was any delay in moving to phase 2, bearing in mind the design had not been completed before phase 1 commenced, they would have to pay for it. Hence, the rush.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I think Mr. Breslin has acknowledged that it would have been better had the Department had the report on the escalation of costs before the Government made the decision.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I want that noted. It was a case of putting the cart before the horse in that we signed the contract for phase 2 knowing there was a problem with costs. Having signed the contract, we then received a report on the escalation of costs. If right was right, that report should have been done before moving on.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I take it Mazars had no role in the big report.
- Public Accounts Committee: National Paediatric Hospital Development Board: Financial Statements 2017 (Resumed) (16 May 2019)
Seán Fleming: I understand Mr. Breslin was concerned about developer optimism and that it would justify the current position. I can understand that. Mr. Breslin was right to be cautious and seek a second view. He then got a report from Mazars. Am I correct that Mr. Breslin is saying he was not happy with it?